132
A. Kozakiewicz et al. / Journal of Molecular Catalysis A: Chemical 326 (2010) 128–140
2.4.2. (1S,2R,4S)-N-(4-methylphenyl)-(2-hydroxy-7,7-
dimethylbicyclo[2.2.1]hept-1-yl) methanesulfonamide
(14)
C, 64.06; H, 8.06; N, 4.15. Found (%): C, 64.04; H, 8.11;
N, 4.19.
Colorless solid (95.8%), mp 102–104 ◦C, [␣]D20 = −44.00 [c = 0.1
(CHCl3)]. 1H, NMR, CDCl3, ı (ppm): 7.18–7.10 (m, 4H, 4 × CH),
6.9–6.8 (bs, 1H, NH), 4.17–4.07 (bs, 1H, CHOH), 3.23–3.14 (bs, 1H,
OH), 3.60, 2.94 (2d, J = 13.8, 2H, CH2S), 2.33 (s, 3H, CH3), 1.83–1.63,
1.60–1.47, 1.16–1.04 (3m, 5, 1, 1H, CH2CH(CH2)2), 1.00, 0.75 (2s,
2 × 3H, 2 × CH3). 13C, NMR, CDCl3, ı (ppm): 135.36 (C), 133.98 (C),
130.24 (2 × CH), 121.23 (2 × CH), 76.42 (CHOH), 51.23 (CH2), 50.34
(C), 48.82 (C), 44.37 (CH), 39.09 (CH2), 30.47 (CH2), 27.29 (CH2),
20.81 (CH3), 20.47 (CH3), 19.83 (CH3). IR(Nujol): 3562 (OH), 3277
(NH), 1511 (HC C), 1332, 1140 (SO2N), 1087 (CO) cm−1. Anal. Calcd
(%) for C17H25N1O3S1: C, 63.13; H, 7.79; N, 4.33. Found (%): C, 63.18;
H, 7.86; N, 4.45.
2.4.6. (1S,2R,4S)-N-methyl-N-phenyl-(2-hydroxy-7,7-
dimethylbicyclo[2.2.1]hept-1-yl) methanesulfonamide
(18)
Colorless solid (88.2%), mp 105–108 ◦C, [␣]D20 = −33.00 [c = 0.1
(CHCl3)]. 1H, NMR, CDCl3, ı (ppm): 7.44–7.39 (m, 4H, 4 × CH),
7.37–7.28 (m, 1H, CH), 4.08 (dt, J = 7.8 Hz, J = 3.9 Hz, 1H, CHOH), 3.36
(s, 3H, CH3), 3.07 (d, J = 3.9 Hz, 1H, OH), 3.37, 2.79 (2d, J = 13.2 Hz, 2H,
CH2S), 1.82–1.61, 1.59–1.46, 1.19–1.05 (3m, 5, 1, 1H, CH2CH(CH2)2),
1.03, 0.77 (2s, 2 × 3H, 2 × CH3). 13C NMR (75 MHz, CDCl3) ı (ppm):
141.33 (C), 129.37 (2 × CH), 127.42 (CH), 126.28 (2 × CH), 76.38
(CHOH), 50.04 (C), 48.76 (C), 47.29 (CH2), 44.44 (CH), 38.91 (CH2),
38.37 (CH3), 30.56 (CH2), 27.28 (CH2), 20.57 (CH3), 19.89 (CH3).
IR (Nujol): 3516 (OH), 1454 (HC C), 1330, 1142 (SO2N), 1087
(CO) cm−1. Anal. Calcd (%) for C17H25N1O3S1: C, 63.13; H, 7.79; N,
4.33. Found (%): C, 63.21; H, 7.84; N, 4.50.
2.4.3. (1S,2R,4S)-N-(2-methylphenyl)-(2-hydroxy-7,7-
dimethylbicyclo[2.2.1]hept-1-yl) methanesulfonamide
(15)
Colorless solid (87.5%), mp 88–90 ◦C, [␣]D20 = −43.00 [c = 0.1
(CHCl3)]. 1H, NMR, CDCl3, ı (ppm): 7.47–7.40 (m, 1H, CH), 7.29–7.21
(m, 2H, 2 × CH), 7.18–7.10 (m, 1H, CH), 6.35 (s, 1H, NH), 4.12
(dt, J = 7.8 Hz, J = 3.9 Hz, 1H, CHOH), 3.13 (d, J = 3.9 Hz, 1H, OH),
3.55, 3.00 (2d, J = 13.5 Hz, 2H, CH2S), 2.34 (s, 3H, CH3), 1.81–1.63,
1.60–1.50, 1.18–1.10 (3m, 5, 1, 1H, CH2CH(CH2)2), 1.03, 0.78 (2s,
2 × 3H, 2 × CH3). 13C NMR (75 MHz, CDCl3) ı (ppm): 134.75 (C),
131.24 (CH), 129.93 (C), 127.40 (CH), 125.89 (CH), 122.06 (CH),
76.38 (CHOH), 52.23 (CH2), 50.48 (C), 48.80 (C), 44.35 (CH), 39.04
(CH2), 30.42 (CH2), 27.30 (CH2), 20.52 (CH3), 19.85 (CH3), 18.05
(CH3). IR (Nujol): 3542 (OH), 3275 (NH), 1497 (HC C), 1325, 1139
(SO2N), 1086 (CO) cm−1. Anal. Calcd (%) for C17H25N1O3S1: C, 63.13;
H, 7.79; N, 4.33. Found (%): C, 63.19; H, 7.82; N, 4.48.
2.4.7. (1S,2R,4S)-N,N-di-iso-butyl-(2-hydroxy-7,7-
dimethylbicyclo[2.2.1]hept-1-yl) methanesulfonamide (19)
Colorless solid (86.5%), mp 82–85 ◦C, [␣]D20 = −36.00 [c = 0.1
(CHCl3)]. 1H, NMR, CDCl3, ı (ppm): 7.44–7.39 (m, 4H, 4 × CH),
7.37–7.28 (m, 1H, CH), 4.08 (dt, J = 7.8 Hz, J = 3.9 Hz, 1H, CHOH),
3.36 (s, 3H, CH3), 3.07 (d, J = 3.9 Hz, 1H, OH), 3.37, 2.79 (2d,
J = 13.2 Hz, 2H, CH2S), 1.82–1.61, 1.59–1.46, 1.19–1.05 (3m, 5, 1, 1H,
CH2CH(CH2)2), 1.03, 0.77 (2s, 2 × 3H, 2 × CH3). 13C NMR (75 MHz,
CDCl3) ı (ppm): 76.49 (CHOH), 56.46 (2 × CH2), 50.23 (C), 49.36
(CH2), 48.63 (C), 44.46 (CH), 38.87 (CH2), 30.78 (CH2), 27.31 (CH2),
27.26 (2 × CH), 20.58 (CH3), 20.12 (4 × CH3), 19.92 (CH3). IR(Nujol):
3521 (OH), 1326, 1139 (SO2N), 1087 (CO) cm−1. Anal. Calcd (%) for
C18H35N1O3S1: C, 62.57; H, 10.21; N, 4.05. Found (%): C, 62.60; H,
10.32; N, 4.41.
2.4.4. (1S,2R,4S)-N-(2,4-dimethylphenyl)-(2-hydroxy-7,7-
dimethylbicyclo[2.2.1]hept-1-yl) methanesulfonamide
2.4.8. (1S,2R,4S)-(2-hydroxy-7,7-dimethylbicyclo[2.2.1]
(16)
hept-1-yl) morpholinesulfonmethane (20)
Colorless solid (94.9%), mp 120–123 ◦C, [␣]D20 = −24.00 [c = 0.1
(CHCl3)]. 1H, NMR, CDCl3, ı (ppm): 7.31–7.23 (m, 1H, CH), 7.08–7.00
(m, 2H, 2 × CH), 6.19 (s, 1H, NH), 4.11 (dt, J = 7.8 Hz, J = 3.9 Hz, 1H,
CHOH), 3.12 (d, J = 3.9 Hz, 1H, OH), 3.51, 2.97 (2d, J = 13.5 Hz, 2H,
CH2S), 2.31 (s, 3H, CH3), 1.85–1.62, 1.60–1.48, 1.17–1.07 (3m, 5,
1, 1H, CH2CH(CH2)2), 1.02, 0.78 (2s, 2 × 3H, 2 × CH3). 13C NMR
(75 MHz, CDCl3) ı (ppm): 136.23 (C), 131.93 (CH), 131.89 (C), 131.04
(C), 127.90 (CH), 123.41 (CH), 76.38 (CHOH), 52.10 (CH2), 50.46 (C),
48.77 (C), 44.37 (CH), 39.00 (CH2), 30.43 (CH2), 27.30 (CH2), 20.87
(CH3), 20.54 (CH3), 19.86 (CH3), 18.07 (CH3). IR(Nujol): 3616 (OH),
3247 (NH), 1498 (HC C), 1334, 1158 (SO2N), 1084 (CO) cm−1. Anal.
Calcd (%) for C18H27N1O3S1: C, 64.06; H, 8.06; N, 4.15. Found (%): C,
64.02; H, 8.10; N, 4.21.
Colorless solid (90.4%), mp 174–176 ◦C, [␣]D20 = −39.00 [c = 0.1
(CH3Ph)]. 1H NMR (300 MHz, CDCl3) ı (ppm): 4.09 (q, J = 4.2, 1H,
CHOH), 3.82–3.76 (m, 4H, 2 × CH2), 3.31–3.25 (m, 4H, 2 × CH2),
3.24, 2.66 (2d, J = 14.1 Hz, J = 13.2 Hz, 2H, CH2S), 3.17 (d, J = 3.9 Hz,
1H, OH), 1.87–1.48, 1.17–1.09 (2m, 6, 1H, CH2CH(CH2)2), 1.07, 0.83
(2s, 6H, 2 × CH3). 13C NMR (75 MHz, CDCl3) ı (ppm): 76.39 (CHOH),
66.45 (2 × CH2), 49.97 (C), 48.81 (C), 46.41 (CH2), 45.86 (2 × CH2),
44.43 (CH), 38.94 (CH2), 30.73 (CH2), 27.31 (CH2), 20.57 (CH3), 19.90
(CH3). IR(Nujol): 3520 (OH), 1334, 1128 (SO2N) 1072(CO) cm−1
Anal. Calcd (%) for C14H25N1O4S1: C, 55.42; H, 8.30; N, 4.62. Found
(%): C, 55.40; H, 8.22; N, 4.58.
.
2.5. Enantioselective addition of diethylzinc to benzaldehyde
2.4.5. (1S,2R,4S)-N-(3,4-dimethylphenyl)-(2-hydroxy-7,7-
dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide
(17)
The reaction of Et2Zn addition was performed according to
Scheme 1, under dry argon. Titanium tetraisopropoxide (0.42 ml,
1.4 mmol) was added to the appropriate ligand (1–20) (0.2 mmol)
dissolved in methylene chloride (5 ml). The mixture was stirred
for 1 h at room temperature, cooled to −50 ◦C, and diethylz-
inc was added (3 ml of 1 M hexane solution, 3 mmol). Stirring
was continued at this temperature, and benzaldehyde (0.1 ml,
1 mmol) was added. The mixture was allowed to warm up to
the room temperature and stirred for the period of time indi-
cated in Table 1. The reaction was quenched with 1 M HCl (10 ml),
then precipitate was filtered out. The organic layer was sepa-
rated and the aqueous layer was extracted three times with 5 ml
of ethyl acetate. Combined organic extracts were washed with
brine, dried over MgSO4 and purified by column chromatography
(hexane/ethyl acetate 5:1) to give 1-phenylpropanol. The enan-
Colorless solid (94.1%), mp 135–138 ◦C, [␣]D20 = −45.00 [c = 0.1
(CHCl3)]. 1H, NMR, CDCl3, ı (ppm): 7.12–7.07 (m, 1H, CH), 7.05–6.91
(m, 2H, 2 × CH), 6.51 (s, 1H, NH), 4.13 (dt, J = 7.5 Hz, J = 4.2 Hz,
1H, CHOH), 3.14 (d, J = 4.2 Hz, 1H, OH), 3.49, 2.95 (2d, J = 13.8 Hz,
2H, CH2S), 2.24 (d, J = 5.7 Hz, 6H, 2 × CH3), 1.87–1.61, 1.59–1.47,
1.18–1.08 (3m, 5, 1, 1H, CH2CH(CH2)2), 1.01, 0.76 (2s, 2 × 3H,
2 × CH3). 13C NMR (75 MHz, CDCl3) ı (ppm): 138.19 (C), 134.16
(C), 134.10 (C), 130.67 (CH), 122.58 (CH), 118.54 (CH), 76.41
(CHOH), 51.27 (CH2), 50.39 (C), 48.83 (C), 44.37 (CH), 39.05 (CH2),
30.49 (CH2), 27.31 (CH2), 20.51 (CH3), 19.91 (CH3), 19.84 (CH3),
19.16 (CH3). IR(Nujol): 3464 (OH), 3126 (NH), 1499 (HC C), 1323,
1137 (SO2N), 1086 (CO) cm−1. Anal. Calcd (%) for C18H27N1O3S1: